Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Predicting Persistent Opioid Use, Abuse and Toxicity Among Cancer Survivors.

Vitzthum LK, Riviere P, Sheridan P, Nalawade V, Deka R, Furnish T, Mell LK, Rose B, Wallace M, Murphy JD.

J Natl Cancer Inst. 2019 Nov 22. pii: djz200. doi: 10.1093/jnci/djz200. [Epub ahead of print]

PMID:
31754696
2.

Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults.

Kumar A, Nalawade V, Riviere P, Sarkar RR, Parsons JK, Murphy JD, Rose BS.

JAMA Netw Open. 2019 Oct 2;2(10):e1913612. doi: 10.1001/jamanetworkopen.2019.13612. No abstract available.

3.

Tobacco smoking and death from prostate cancer in US veterans.

Riviere P, Kumar A, Luterstein E, Vitzthum LK, Nalawade V, Sarkar RR, Bryant AK, Einck JP, Mundt AJ, Murphy JD, Rose BS.

Prostate Cancer Prostatic Dis. 2019 Oct 17. doi: 10.1038/s41391-019-0178-6. [Epub ahead of print]

PMID:
31624316
4.

Risk of Pelvic Fracture With Radiation Therapy in Older Patients.

Vitzthum LK, Park H, Zakeri K, Heide ES, Nalawade V, Mundt AJ, Vaida F, Murphy JD, Mell LK.

Int J Radiat Oncol Biol Phys. 2019 Oct 11. pii: S0360-3016(19)33874-X. doi: 10.1016/j.ijrobp.2019.10.006. [Epub ahead of print]

PMID:
31610251
5.

Incorporating palliative radiotherapy education into hospice and palliative medicine fellowship training: a feasibility study.

Martin EJ, Nalawade VV, Murphy JD, Jones JA.

Ann Palliat Med. 2019 Sep;8(4):436-441. doi: 10.21037/apm.2019.04.02. Epub 2019 May 1.

6.

Box-Behnken design directed optimization for sensitivity assessment of anti-platelet drugs.

Nalawade V, Vora A.

Drug Dev Ind Pharm. 2019 Sep;45(9):1515-1522. doi: 10.1080/03639045.2019.1634092. Epub 2019 Jul 3.

PMID:
31267803
7.

Pneumococcal Vaccination Utilization Among Hispanic Long-Term Colorectal Cancer Survivors: Cross-Sectional Assessment of Claims.

Moran RJ, Waalen J, Murphy J, Nalawade V, Schiaffino M.

JMIR Public Health Surveill. 2019 May 13;5(2):e12603. doi: 10.2196/12603.

8.

Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy.

Deka R, Simpson DR, Panizzon MS, Hauger RL, Riviere P, Nalawade V, McKay R, Murphy JD, Rose BS.

Prostate Cancer Prostatic Dis. 2019 Dec;22(4):600-608. doi: 10.1038/s41391-019-0150-5. Epub 2019 Apr 15.

PMID:
30988408
9.

Claims-Based Approach to Predict Cause-Specific Survival in Men With Prostate Cancer.

Riviere P, Tokeshi C, Hou J, Nalawade V, Sarkar R, Paravati AJ, Schiaffino M, Rose B, Xu R, Murphy JD.

JCO Clin Cancer Inform. 2019 Mar;3:1-7. doi: 10.1200/CCI.18.00111.

10.

Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy.

Deka R, Rose BS, Bryant AK, Sarkar RR, Nalawade V, McKay R, Murphy JD, Simpson DR.

Cancer. 2019 Apr 1;125(7):1070-1080. doi: 10.1002/cncr.31982. Epub 2019 Feb 12.

PMID:
30748008
11.

Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy.

Deka R, Simpson DR, Bryant AK, Nalawade V, McKay R, Murphy JD, Rose BS.

JAMA Oncol. 2018 Nov 1;4(11):1616-1617. doi: 10.1001/jamaoncol.2018.4423. No abstract available.

12.
13.

Structural elucidation of chemical constituents from Benincasa hispida seeds and Carissa congesta roots by gas chromatography: Mass spectroscopy.

Doshi GM, Nalawade VV, Mukadam AS, Chaskar PK, Zine SP, Somani RR, Une HD.

Pharmacognosy Res. 2015 Jul-Sep;7(3):282-93. doi: 10.4103/0974-8490.157179.

Supplemental Content

Loading ...
Support Center